Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Operating income as a percentage of revenue
Latest
-566038.89%
↓ 190% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-194953.83%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -566038.89% | +3.8% |
| 2024 | -588122.95% | -209.5% |
| 2023 | -190006.15% | -85917.7% |
| 2022 | -220.89% | +89.0% |
| 2021 | -2016.68% | +26.2% |
| 2020 | -2732.56% | +82.4% |
| 2019 | -15538.66% | - |